BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Earnings
Ohr Pharmaceutical (OHRP) To Announce Fiscal 2014 Financial Results And Host Conference Call On Monday, December 22 12/19/2014
CAPNIA, Inc. Reports Third Quarter 2014 Financial Results 12/19/2014
NeuroDerm Ltd. (NDRM) Announces Third Quarter 2014 Financial Results And Provides A Corporate Update 12/18/2014
BioReference Laboratories, Inc. (BRLI) Announces Quarterly And Yearly Record Revenues, Net Income And Patient Volumes 12/18/2014
Amgen (AMGN) Announces 30 Percent Increase In 2015 First Quarter Dividend 12/18/2014
Neogen Corporation (NEOG) Reports 26% Increase In Net Income 12/18/2014
Baxter International, Inc. (BAX) Fourth Quarter 2014 Financial Results Conference Call 12/18/2014
PAREXEL International (PRXL) Announces Date Of Second Quarter Fiscal Year 2015 Earnings Release And Conference Call 12/17/2014
Bioanalytical Systems, Inc. (BASI) To Release Fourth Quarter Fiscal 2014 Results On Monday December 22, 2014; Conference Call & Webcast Set For 11:00 A.M. EST 12/17/2014
Bristol-Myers Squibb Company (BMY) To Announce Results For Fourth Quarter, Full Year 2014 On January 27 12/17/2014
Tenax Therapeutics (TENX) Announces Second Quarter Fiscal Year 2015 Financial Results 12/17/2014
Eagle Pharmaceuticals (EGRX) Reports Fourth Quarter And Year End 2014 Financial Results 12/17/2014
Coherus Biosciences Reports Third Quarter 2014 Financial And Operating Results 12/16/2014
PDL BioPharma, Inc. (PDLI) Completes Regular Quarterly Dividend Payment 12/16/2014
Helix Biopharma (TSX:HBP) Announces Q1 Fiscal 2015 Results 12/16/2014
Landauer (LDR)Announces Date And Time For Announcement Of Fiscal Fourth Quarter 2014 Results And Conference Call 12/15/2014
Origin Agritech Limited (SEED) To Announce Fiscal 2014 Annual Financial Results On January 8th, 2015 12/15/2014
Xenon Pharmaceuticals Inc. Reports Third Quarter 2014 Financial Results 12/15/2014
Polydex Pharmaceuticals (POLXF) Reports 3rd Quarter Financial Results 12/15/2014
Bioanalytical Systems, Inc. (BASI) To Release Fourth Quarter Fiscal 2014 Results On Wednesday December 17, 2014; Conference Call & Webcast Set For 11:00 A.M. EST 12/15/2014
Champions Oncology, Inc. (CSBR) Reports Results For The Second Quarter Ended October 31, 2014 12/12/2014
Peregrine Pharmaceuticals, Inc. (PPHM) Reports Second Quarter Fiscal Year 2015 Financial Results And Recent Developments 12/12/2014
Abbott Laboratories (ABT) Announces Increase In Quarterly Dividend 12/12/2014
Abzena PLC Release: Interim Results For The Six Months Ended 30 September 2014 12/11/2014
Tenax Therapeutics (TENX) To Provide Corporate Update And Discuss Second Quarter Fiscal Year 2015 Financial Results On December 17, 2014 12/11/2014
BioReference Laboratories, Inc. (BRLI) Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2014 12/11/2014
Synergetics USA, Inc. (SURG) Reports First Quarter Of Fiscal Year 2015 Results 12/11/2014
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 12/11/2014
Parnell Pharmaceuticals Holdings Announces Change In Fiscal Year-End 12/10/2014
Champions Oncology, Inc. (CSBR) To Announce Second Quarter Financial Results On Friday, December 12 12/10/2014
Dynasil Schedules Fiscal 2014 Financial Results Conference Call 12/10/2014
Enzo Biochem (ENZ) Reports Strong Fiscal First Quarter Results 12/10/2014
Bristol-Myers Squibb Company (BMY) Announces Dividend 12/10/2014
Scancell Holdings Plc Interim Results For The Six Months Ended 31 October 2014 12/10/2014
Patterson Companies Declares Quarterly Dividend 12/10/2014
AVANIR Pharmaceuticals (AVNR) Cancels Previously Scheduled Earnings Call 12/8/2014
OncoSec Medical Inc. Announces First Quarter Results For Fiscal Year End 2015 12/8/2014
Aceto Corporation Board Of Directors Declares Quarterly Cash Dividend 12/5/2014
Eagle Pharmaceuticals (EGRX) To Discuss 2014 Fourth Quarter And Year-End Financial Results On December 17, 2014 12/5/2014
Coherus Biosciences To Host Earnings Conference Call On December 15 12/5/2014
Peregrine Pharmaceuticals, Inc. (PPHM) To Report Second Quarter Fiscal 2015 Financial Results After Market On December 10, 2014 12/5/2014
Consort Medical Interim Results For The Six Months Ended 31 October 2014 12/4/2014
Simulations Plus (SLP) Reports First Quarter FY2015 Preliminary Revenues 12/3/2014
Nevro Corp Reports Third Quarter Financial Results 12/3/2014
Auris Medical AG (EARS) Q3 2014 Earnings Release 12/3/2014
AVANIR Pharmaceuticals (AVNR) Announces Date Of Fiscal 2014 Fourth Quarter Financial Results And Conference Call 12/2/2014
Synergetics USA, Inc. (SURG) Announces Conference Call To Review First Quarter Of Fiscal Year 2015 Results 12/2/2014
GW Pharmaceuticals plc Reports 2014 Q4 And Full Year Financial Results 12/2/2014
Pivotal Therapeutics Inc. Announces Third Quarter Accomplishments And Financial Results 12/1/2014
Auris Medical AG (EARS) To Announce Third Quarter 2014 Financial Results And Host Conference Call On Wednesday, December 3, 2014 12/1/2014
uniQure Announces Results For The Third Quarter Of 2014 12/1/2014
iCo Therapeutics Inc. Announces Third Quarter 2014 Financial Results And Corporate Update 12/1/2014
Antibe Therapeutics Inc. Reports Q2 2015 Interim Financial And Operating Results 12/1/2014
XTL Biopharmaceuticals Ltd. (XTLB) Provides Financial and Operational Update For the Third Quarter of 2014 12/1/2014
Simulations Plus (SLP) Reports FY2014 And Fourth Quarter FY2014 Financial Results 11/26/2014
Arrowhead Research Corporation (ARWR) Reports Fiscal 2014 Year End Financial Results 11/26/2014
China Cord Blood Corporation Reports Financial Results For The Second Quarter And First Half Of Fiscal 2015 11/26/2014
Analogic Corporation (ALOG) Announces Timing For First Quarter 2015 Earnings Conference Call And Webcast 11/26/2014
Pall Corporation (PLL) Reports First Quarter Results 11/25/2014
Proteon Therapeutics, Inc. (PRTO) Announces Third Quarter 2014 Financial Results 11/25/2014
Enanta Pharmaceuticals, Inc. Reports Financial Results For its Fiscal Fourth Quarter And Year Ended September 30, 2014 11/24/2014
GW Pharmaceuticals To Report Q4, Year-End 2014 Financial Results And Host Conference Call On 2 December, 2014 11/24/2014
Bio Blast Pharma Reports Third Quarter Financial Results 11/21/2014
Taxus Cardium (CRXM) Reports On Third Quarter 2014 Results And Corporate Development Activities 11/20/2014
Medivir AB (MVRBF): Interim Report, January – September 2014 11/20/2014
Cellular Biomedicine Group (CBMG) Reports Third Quarter 2014 Financial Results And Provides Business Highlights 11/20/2014
EDAP TMS S.A. (EDAP) Reports Continued Strong Growth In Third Quarter 2014 11/20/2014
Sientra, Inc. (SIEN) Reports Third Quarter 2014 Financial Results 11/20/2014
NeuroVive Pharmaceutical AB: Interim Report 1 Jan. 2014 To 30 Sep. 2014 11/19/2014
Mallinckrodt plc Reports Fiscal 2014 Fourth Quarter And Fiscal 2014 Financial Results 11/19/2014
Marina Biotech, Inc. (MRNA) Announces Third Quarter 2014 Financial Results 11/19/2014
Arrowhead Research Corporation (ARWR) To Report Fiscal 2014 Fourth Quarter And Year End Financial Results 11/19/2014
Palatin Technologies (PTN) Reports First Quarter Fiscal Year 2015 Results; Teleconference And Webcast To Be Held On November 18, 2014 11/18/2014
Omega Protein Corporation (OME) Announces Third Quarter 2014 Financial Results 11/18/2014
China Cord Blood Corporation To Report Second Quarter And First Half Of Fiscal 2015 Financial Results 11/18/2014
Protea Biosciences, Inc. Announces 2014 Third Quarter Financial Results 11/18/2014
Affimed Reports Financial Results For Third Quarter 2014 11/18/2014
Cardio3 BioSciences Announces Q3 2014 Business Update 11/18/2014
Agilent Technologies Inc. (A) Reports Fourth-Quarter 2014 Results 11/18/2014
MYOS (MYOS) Reports 2014 Third Quarter Results And Provides Business Update 11/18/2014
Skystar Bio-Pharmaceutical (CGPN) To File Financial Results For Third Quarter Of Fiscal 2014 On Friday, November 14 11/18/2014
Skystar Bio-Pharmaceutical (CGPN) Reports Third Quarter Fiscal Year 2014 Financial Results 11/18/2014
ContraFect Corporation (CFRXU) Announces Third Quarter 2014 Results 11/18/2014
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results For The Second Quarter Of Fiscal Year 2015 11/18/2014
Fermentalg Q3 2014 Financial information 11/17/2014
Kite Pharma, Inc. (KITE) Reports Third Quarter 2014 Results 11/17/2014
Tengion Inc. Provides Clinical Update And Reports Third Quarter 2014 Financial Results And Cash Position 11/17/2014
VBI Reports Third Quarter 2014 Financial Results And Provides Update On CMV Vaccine Development 11/17/2014
Arno Therapeutics Reports Third Quarter 2014 Financial And Business Update 11/17/2014
Alcobra (ADHD) Announces Third Quarter Financial Results And Provides Corporate Update 11/17/2014
ConvaTec Announces 2014 Third Quarter Earnings Call 11/17/2014
Inergetics, Inc.: 2014 Third Quarter Earnings Announcement 11/17/2014
Nephros Inc. (NEP) Reports Third Quarter 2014 Financial Results And Announces Launch Of Rights Offering 11/17/2014
Anthera Pharmaceuticals, Inc. (ANTH) Reports 2014 Third Quarter Financial Results And Operational Update 11/17/2014
Sinovac Biotech Ltd. (SVA) Reports Unaudited Third Quarter Financial Results 11/17/2014
ULURU Inc. Reports Third Quarter 2014 Financial Results 11/17/2014
Pressure BioSciences, Inc. (BBII) Reports Third Quarter 2014 Financial Results And Provides Business Update 11/17/2014
ProSensa Holding N.V. (RNA) Announces 3rd Quarter 2014 Financial Results And Recent Corporate Developments 11/17/2014
WuXi PharmaTech Co., Ltd. Reports Record Revenues, CapEx Spending 11/17/2014
Sevion Therapeutics Reports First Quarter 2015 Financial Results 11/17/2014
Corium International, Inc. Reports Fiscal Year-End 2014 Financial Results And Recent Corporate Developments 11/17/2014
Enumeral Biomedical (ENUM) Reports Third Quarter 2014 Financial Results 11/17/2014
Bio-Path Holdings, Inc. (BPTH) Reports Third Quarter 2014 Operational And Financial Results 11/17/2014
Enanta Pharmaceuticals, Inc. To Host Conference Call To Discuss Financial Results For The Fiscal Fourth Quarter And Year Ended September 30, 2014 11/17/2014
Retrophin (RTRX) Reports Third Quarter 2014 Financial Results 11/14/2014
BIOQUAL Presents Financial Results For Fiscal Year 2014 And Declares Dividend 11/14/2014
Nuo Therapeutics Reports Third Quarter 2014 Financial Results 11/14/2014
AxoGen, Inc. (AXGN) Reports 58% Third Quarter Revenue Growth 11/14/2014
Ruthigen Reports Fiscal Second Quarter 2015 Financial Results 11/14/2014
Kindred Bio (KIN) Announces Third Quarter 2014 Financial Results 11/14/2014
Intrexon Corporation Announces Third Quarter 2014 Financial Results 11/14/2014
Celator Pharmaceuticals, Inc. Announces Business Update And Third Quarter 2014 Financial Results 11/14/2014
Pfenex Inc. (PFNX) Reports Third Quarter 2014 Results And Provides Business Update 11/14/2014
Dyadic International, Inc. Reports Q3 2014 Financial Results 11/14/2014
Capstone Therapeutics (CAPS) Will Provide An Operating Update And Announces Third Quarter 2014 Financial Results 11/14/2014
CollabRx, Inc. Reports Second Quarter Fiscal Year 2015 Financial Results 11/14/2014
Cesca Therapeutics Reports First Quarter Fiscal 2015 Results 11/14/2014
Calithera Biosciences, Inc. (CALA) Reports Financial Results For The Fiscal Quarter Ended September 30, 2014 11/14/2014
Palatin Technologies (PTN) To Report First Quarter Fiscal Year 2015 Results 11/14/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Third Quarter 2014 Financial Results 11/14/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Reports Financial Results For Third Quarter And Nine Months Ended September 30, 2014 11/14/2014
China Pharma Holdings, Inc. (CPHI.OB) Reports Third Quarter 2014 Financial Results 11/14/2014
Synthetic Biologics, Inc. (SYN) Reports Third Quarter 2014 Financial Results And Operational Highlights 11/14/2014
CASI Pharmaceuticals  (ENMD) Reports Third Quarter 2014 Financial Results 11/14/2014
Flexion Therapeutics (FLXN) Reports Third-Quarter 2014 Financial Results 11/14/2014
Vital Therapies, Inc. (VTI) (VTL) Announces Third Quarter 2014 Financial Results And Provides A Corporate Update 11/14/2014
Agile Therapeutics, Inc. Reports Third Quarter 2014 Financial Results 11/14/2014
Argos Therapeutics, Inc. (ARGS) Reports Third Quarter 2014 Financial Results And Operational Highlights 11/14/2014
Evoke Pharma, Inc. Reports Third Quarter 2014 Results 11/14/2014
Ocera Therapeutics, Inc. (OCRX) Reports Third Quarter 2014 Financial Results 11/14/2014
Nymox Pharmaceutical (NYMX) Reports Third Quarter 2014 Financial Results 11/14/2014
Elite Pharmaceuticals, Inc. (ELI) To Host Quarterly Business Update Call On Wednesday, November 19, 2014 11/14/2014
FEI Company Announces Quarterly Cash Dividend Of $0.25 Per Share 11/14/2014
Cerulean Pharma Inc. (CERU) Reports Third-Quarter 2014 Corporate Highlights And Financial Results 11/14/2014
Emisphere Technologies, Inc. (EMIS) Announces Financial Results For The Third Quarter 2014 11/14/2014
Heat Biologics Reports 2014 Third Quarter Financial Results 11/14/2014
Loxo Oncology (LOXO) Announces Third Quarter 2014 Financial Results 11/14/2014
Cord Blood America, Inc. Announces 2014 Third Quarter Financial Results 11/14/2014
Biostar Pharmaceuticals, Inc. (BSPM) Announces Third Quarter 2014 Financial Results 11/14/2014
ALK-Abello A/S Release: Nine-Month Interim Report (Q3) 2014 11/14/2014
Titan Pharmaceuticals (TTP) Announces Third Quarter 2014 Financial Results 11/14/2014
ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) (QGLY) Reports Financial Results For The Three And Nine Months Ended September 30, 2014 11/14/2014
Catalent Reports First Quarter Fiscal Year 2015 Results 11/14/2014
Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January – September 2014 11/14/2014
Stellar Biotechnologies, Inc. Reports Year-End 2014 Financial Results 11/14/2014
22nd Century Group, Inc. Reports Third Quarter 2014 Financial Results 11/14/2014
Imprimis Pharmaceuticals (immy) Reports On Third Quarter 2014 Financial Results And Provides Update On Business Developments 11/13/2014
Transition Therapeutics Inc. (TTH.TO) Announces First Quarter Fiscal 2015 Financial Results 11/13/2014
WuXi PharmaTech Co., Ltd. Announces Third-Quarter 2014 Results 11/13/2014
RXi Pharmaceuticals (RXII) Reports Financial Results For The Third Quarter Of 2014 11/13/2014
CytoSorbents, Inc. Achieves First $1M In Quarterly Cytosorb Sales In Q3 2014 11/13/2014
OXiGENE (OXGN) Reports Third Quarter 2014 Financial Results 11/13/2014
Amphastar Pharmaceuticals, Inc. (AMPH) Reports Revenues Of $59.7 Million For The Third Quarter Ended September 30, 2014 11/13/2014
Conatus Pharmaceuticals Inc. Reports Third Quarter 2014 Financial Results And Program Updates 11/13/2014
BrainStorm Cell Therapeutics Inc. Announces Financial Results For The Third Quarter Of 2014 And Provides Corporate Update 11/13/2014
ReVance Therapeutics, Inc. (RVNC) Releases Third Quarter 2014 Results 11/13/2014
Otonomy, Inc. (OTIC) Reports Third Quarter 2014 Financial Results And Provides Corporate Update 11/13/2014
Dermira Reports Third Quarter 2014 Financial Results And Provides Corporate Update 11/13/2014
Vitae Pharmaceuticals, Inc. (VTAE) Reports Third Quarter 2014 Operating And Financial Results 11/13/2014
Ablynx (ABLYF) Announces Its Business Update For The First Nine Months Of 2014 11/13/2014
Rexahn Pharmaceuticals, Inc. (RNN) Reports Third Quarter 2014 Financial Results And Pipeline Update 11/13/2014
VBL Therapeutics (VBLX) Announces Third Quarter 2014 Financial Results 11/13/2014
Marinus Pharmaceuticals (MRNS) Provides Business Update And Reports Third Quarter 2014 Financial Results 11/13/2014
Enzymotec Reports Third Quarter 2014 Unaudited Financial Results 11/13/2014
Aastrom Biosciences, Inc. (ASTM) Reports Third-Quarter 2014 Financial Results 11/13/2014
SCYNEXIS, Inc. (SCYX) Reports Third Quarter 2014 Financial Results 11/13/2014
Innocoll, Inc. (INNL) Announces Third Quarter 2014 Financial and Operating Results 11/13/2014
RestorGenex Reports Third Quarter 2014 Financial Results 11/13/2014
La Jolla Pharmaceutical Company (LJPC) Announces Third Quarter And Year-To-Date 2014 Financial Results And Corporate Highlights 11/13/2014
Sophiris Bio Inc. (SPHS) Reports Third Quarter Financial Results 11/13/2014
Sangui BioTech International Inc. (SGBI): Revenues Improved In The First Quarter Of The 2015 Financial Year 11/13/2014
Eleven Biotherapeutics (EBIO) Reports Third Quarter 2014 Financial Results 11/13/2014
ImmuCell (ICCC) Announces Financial Results For Third Quarter Of 2014 11/13/2014
Egalet Reports Third Quarter 2014 Financial Results And Provides Business Update 11/12/2014
Galmed Pharmaceuticals Provides Business Update And Reports Year-To-Date 2014 Financial Results 11/12/2014
MacroGenics, Inc. (MGNX) Provides Update On Corporate Progress And Third Quarter 2014 Financial Results 11/12/2014
Fate Therapeutics (FATE) Reports Third Quarter 2014 Financial Results 11/12/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Third Quarter 2014 Financial Results 11/12/2014
Corium International, Inc. To Report Fiscal Year-End 2014 Financial Results On Monday, November 17, 2014 11/12/2014
Zafgen (ZFGN) Reports Third Quarter 2014 Financial Results 11/12/2014
Cellectar Biosciences  (NVLT) Reports Third Quarter 2014 Financial Results And Recent Highlights 11/12/2014
Supernus Pharmaceuticals (SUPN) Announces Third Quarter 2014 Results 11/12/2014
Evotec AG (EVTG.F) Reports Results Of The First Nine Months Of 2014 11/12/2014
Celladon Corporation Reports Third Quarter 2014 Financial Results And Recent Highlights 11/12/2014
Atara Biotherapeutics (ATRA) Announces Third Quarter 2014 Operating Results 11/12/2014
Cesca Therapeutics To Announce First Quarter Fiscal 2015 Results On November 13, 2014 11/12/2014
Immune Design Corporation (IMDZ) Reports Third Quarter 2014 Financial Results And Provides Corporate Update 11/12/2014
Stemline Therapeutics, Inc. (STML) Reports Third Quarter 2014 Financial Results And Provides Corporate Update 11/12/2014
GenVec Inc. (GNVC) Reports Third Quarter 2014 Financial Results 11/12/2014
NovaBay Pharmaceuticals, Inc. (NBY) Reports Third Quarter 2014 Financial Results And A Clinical/Business Update 11/12/2014
Bioniche Life Sciences Inc. (BNC) Reports MCNA Update & First Quarter Results 11/12/2014
Capricor Therapeutics, Inc. Reports Third Quarter 2014 Financial & Business Highlights 11/12/2014
Aurinia (ISA.TO) Reports Third Quarter 2014 Financial Results 11/12/2014
Avalanche Biotechnologies (AAVL) Reports Third Quarter 2014 Financial Results 11/12/2014
Dipexium Pharmaceuticals (DPRX) Reports Third Quarter 2014 Financial And Operational Results 11/12/2014
Kamada Ltd. (KMDA) Announces Third Quarter 2014 Financial Results 11/12/2014
bluebird bio (BLUE) Reports Fiscal Third Quarter 2014 Financial Results 11/12/2014
Ocular Therapeutix, Inc. (OCUL) Reports Third Quarter 2014 Financial Results 11/12/2014
Concert Pharmaceuticals, Inc. (CNCE) Reports Third Quarter 2014 Financial Results And Provides Update On CTP-354 Program 11/12/2014
Veloxis Pharmaceuticals A/S (VELO) Announces Financial Results For The First Nine Months Of 2014 And Improves The Full Year Outlook 11/12/2014